Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma
Tissue context can dictate why a gene can have seemingly opposing functions in different settings. ELF3 is tumor suppressive in many cancers of epithelial origin but in lung cancer, the authors describe an oncogenic role in the adenocarcinoma histology of non-small cell lung cancer.
Guardado en:
Autores principales: | Katey S. S. Enfield, Erin A. Marshall, Christine Anderson, Kevin W. Ng, Sara Rahmati, Zhaolin Xu, Megan Fuller, Katy Milne, Daniel Lu, Rocky Shi, David A. Rowbotham, Daiana D. Becker-Santos, Fraser D. Johnson, John C. English, Calum E. MacAulay, Stephen Lam, William W. Lockwood, Raj Chari, Aly Karsan, Igor Jurisica, Wan L. Lam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97564470fd144a769823f07282f004b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Redundancy in ELF: A Corpus-Based Study on Negative and Modal Concord
por: Dorota Watkowska
Publicado: (2021) -
Triterpenoid Saponins from the Cultivar “Green Elf” of <i>Pittosporum tenuifolium</i>
por: David Pertuit, et al.
Publicado: (2021) -
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
por: Maria Kalyuga, et al.
Publicado: (2012) -
The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis.
por: Qingsong Xie, et al.
Publicado: (2014) -
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate
por: Akhilesh Pandey, et al.
Publicado: (2020)